Molecular and biological markers 2

• FC 22-01 • Association between integration of high-risk HPV genomes detected by molecular combing and the severity and/or clinical outcome of cervical lesions See abstract > A. Anne JACQUET • FC 22-02 • HPV-16 variant´s and IGF1R overexpression induces resistance to radiotherapy in uterine cervical cancer See abstract > P. P.M.A. MORENO-ACOSTA • FC 22-03 • Effects of HPV 16 E6 and E7 oncogenes on genomic stability in HCT116 cells See abstract > L. L. GANSS • FC 22-04 • Staging of cervical pre-cancer using single cell mRNA E6/E7 and cell cycle See abstract > B. Bruce Patterson • FC 22-05 • Cell adhesion and cell-cell signalling are affected by HPV integration, while deregulation of specific pathways occur during the CIN3 to cervical cancer transition See abstract > K. K. PAPPA • FC 22-06 • Discovery of biomarkers for in vivo imaging of cervical precancers in the study to understand cervical cancer early endoints and determinants See abstract > T. T. LITWIN • FC 22-07 • Detecting cervical cancer via elevated HPV oncoproteins E6/E7- accuracy of the ONCOE6™ cervical test See abstract > J. Johannes SCHWEIZER • FC 22-08 • Genome-wide microRNA profiling of hrHPV-positive self-samples: Promising triage markers for early detection of cervical cancer See abstract > B. B. SNOEK • FC 22-09 • Prognosis of donor patients according to the characteristics of Patients derived xenograft (PDX) tumor in gynecological cancer See abstract > G. G.S. SOHN